Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3
×
bristol-myers squibb
celgene
intercept pharmaceuticals
2019
4d molecular therapeutics
abbvie
acne
activism
acute hepatic porphyria
agenus
alnylam pharmaceuticals
amy heimberer
astrazeneca
What
disease
3
×
drug
3
×
bio
liver
race
roundup
advanced
alnylam’s
alzheimer's
approval
approved
bad
bff
brain
cancer
case
companies
conference
deals
devoted
digital
doses
easl
epidemic
failed
fatty
fda
fight
form
fortune
frenzied
gene
goes
growing
help
kicked
known
led
major
medicine
Language
Current search:
disease
×
drug
×
" wisconsin top stories "
×
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
